12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers Tilray Brands (NASDAQ:TLRY) shares rose 17.9% to $1.98 during Wednesday’s pre-market session. The company’s market cap stands…
BrainsWay Announces Significant Expansion In Western And Central U.S.
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced significant
The Latest Analyst Ratings for BrainsWay
BrainsWay (NASDAQ:BWAY) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Earnings Scheduled For May 17, 2023
Companies Reporting Before The Bell
• Wix.com (NASDAQ:WIX) is likely to report quarterly earnings at $0.14 per share on revenue of $369.35 million.
BrainsWay: Q1 Earnings Insights
BrainsWay (NASDAQ:BWAY) reported its Q1 earnings results on Wednesday, May 17, 2023 at 07:30 AM. Here’s what investors…
Earnings Outlook For BrainsWay
BrainsWay (NASDAQ:BWAY) is set to give its latest quarterly earnings report on Wednesday, 2023-05-17. Here’s what investors need…
Neuronetics Settles Unfair Competition Related Litigation Against BrainsWay
Neuronetics Inc (NASDAQ:STIM) settled the litigation filed in the District of Delaware against BrainsWay Ltd (NASDAQ:BWAY) and BrainsWay USA Inc. for unfair competition. Under the…
HC Wainwright & Co. Maintains Buy on BrainsWay, Lowers Price Target to $13
HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and lowers the price target from $16 to $13.
S&P 500 Down 0.8%; Lowe’s Earnings Top Expectations
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 1.5% on Wednesday.
BrainsWay And NOCD Launch Collaboration To Increase Awareness Of OCD Treatments
BURLINGTON, Mass. and JERUSALEM, Oct. 11, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive